We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.92 | 6.11295681063 | 15.05 | 16.51 | 14.057 | 137834 | 14.85928978 | CS |
4 | 1.15 | 7.75978407557 | 14.82 | 16.51 | 13.855 | 340007 | 14.78522871 | CS |
12 | -1.76 | -9.92667794698 | 17.73 | 19.77 | 13.855 | 359460 | 16.32606819 | CS |
26 | -3.4 | -17.5529168818 | 19.37 | 19.8 | 13.715 | 315595 | 16.37594627 | CS |
52 | 6.55 | 69.5329087049 | 9.42 | 22.188 | 8.62 | 239663 | 16.2751478 | CS |
156 | -1.11 | -6.49882903981 | 17.08 | 22.188 | 4.81 | 120170 | 14.18147334 | CS |
260 | -0.31 | -1.90417690418 | 16.28 | 33.01 | 4.03 | 103377 | 16.35352683 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions